SUN Surgical Innovations Group plc
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through SI Brand, Original Equipment Manufacturer (OEM), and Distribution segments. The company provides YelloPort Elite port access systems; YelloPort + Resposable port access systems; LogiCut, a disposable laparoscopic scissors; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; and minimally invasive technology products for precision engineering applications. In addition, the company distributes specialist medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.…
Industry Peers
Medical DevicesKey Statistics
About Surgical Innovations Group (LON: SUN)
›
Surgical Innovations Group (LON: SUN) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 93 employees.
The shares were at 0.5500 GBp on 19 November 2026, down 4.3% over 52 weeks. Its 52-week range is 0.3055 GBp to 0.6000 GBp: the price is 8.3% below the high and 80.0% above the low.
Its market capitalisation is 5.13M GBP.
Surgical Innovations Group reports return on equity of -11.7%, an operating margin of -8.9% and revenue down 2.1% year over year.
Its debt exceeds its cash by 896.00K GBP, a debt-to-equity ratio of 0.09. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 1.400 GBp is 154.5% above the current price.